About Collatamp G

Current methods of prevention—proper systemic antibiotic use, skin preparation and surgical techniques—have greatly reduced the number of surgical site infection cases.

Despite increased practice of these methods, surgical patients are still at high risk of developing a surgical site infection—and the impact of such infections is too critical to ignore.

Patients who develop a surgical site infection:

Are twice as likely to die
Are more likely to spend time in an intensive care unit after surgery
Have an increased length of hospital stay
Are five times more likely to be readmitted to hospital than a patient without a surgical site infection

What Can Be Done to Further Reduce the Risk of Surgical Site Infection?

For over 20 years, surgeons in Europe and throughout the world have been using Collatamp G to reduce the risk of and treat surgical site infections.

Now, hospitals across Canada are ordering and trialing it as well.

Collatamp G is a lyophilized collagen sponge impregnated with the aminoglycoside antibiotic gentamicin that gives you the ability to reduce the rate of surgical site infections 50-85%.

By using Collatamp G to prevent and treat surgical site infections, your patients':

Recovery time will be easier
Need for repeat surgery will be reduced
Need for readmission to hospital will decrease
Risk of dying will lower

Collatamp G has been used in over 2 million patients over 20 years globally, and, to date, there have been no reported side effects.

How Does Collatamp G Treat Existing Surgical Site Infections?

As well as preventing surgical site infections, Collatamp G is widely used to treat existing infections.

Indications include:

osteomyelitis
infected hernia mesh
infected joints

A Powerful, Cost-Effective Method of Reducing the Risk of Surgical Site Infection

At $4,000 per patient, surgical site infections cost the Canadian healthcare system over $200 million each year.

Better patient outcomes—a 50-85% reduction in surgical site infections— also translate into enormous hospital savings and improved surgical throughput.

How does Collatamp G work?

Collatamp G is a localized drug-delivery system that is based on type-1 collagen matrix derived from bovine achilles tendon.

The collagen sponge is saturated with gentamicin, a powerful broad-spectrum antibiotic.

Collatamp G is a strong, effective adjunct to the lower dose prophylactic antibiotic protocols that are already used at your hospital.

By delivering a high localized dose of gentamicin directly to the surgical site, Collatamp G kills bacteria that may be antibiotic-resistant at lower doses.

Collatamp G maintains a high concentration of drugs at the target site, while avoiding the risk of systemic toxicity and associated side effects.

Advantages of a Collagen-Based Drug Delivery System

Many device-drug combination products—pumps for continuous infusion of local anesthetics, medicated stents and bone cements carrying an antibiotic—work well as localized delivery systems.

Collagen, however, has the advantage of being a natural and well-established biocompatible material with proven wound-healing and hemostatic properties.

The collagen matrix of Collatamp G accelerates hemostasis and speeds wound healing.

Collatamp G Safely Delivers the Appropriate Dosage

Gentamicin is released by a combination of diffusion and natural enzymatic breakdown of the collagen matrix.

This provides both rapid and prolonged release, which has been mathematically modelled.

The matrix itself is fully resorbable within one to seven weeks according to implant location (i.e., well-vascularized areas versus cavities).

Interested in Learning More?

Find out how you can use Collatamp G to reduce surgical site infections.

About Surgical Site Infections

Preventing and Treating Surgical Site Infections